Liu Y, Su Y, Chen L, Li A, Ma Z
Ann Med. 2024; 56(1):2397568.
PMID: 39215680
PMC: 11370671.
DOI: 10.1080/07853890.2024.2397568.
Liu Y, Song Y, He Y, Kong Z, Li H, Zhu Y
Biol Direct. 2023; 18(1):65.
PMID: 37817224
PMC: 10565980.
DOI: 10.1186/s13062-023-00422-5.
Lee E, Cheung J, Bialkowska A
Cancers (Basel). 2023; 15(9).
PMID: 37173904
PMC: 10177156.
DOI: 10.3390/cancers15092430.
Bernhardt C, Sock E, Frob F, Hillgartner S, Nemer M, Wegner M
Nucleic Acids Res. 2022; 50(20):11509-11528.
PMID: 36318265
PMC: 9723594.
DOI: 10.1093/nar/gkac953.
Tsytsykova A, Wiley G, Li C, Pelikan R, Garman L, Acquah F
iScience. 2022; 25(8):104839.
PMID: 35996584
PMC: 9391581.
DOI: 10.1016/j.isci.2022.104839.
Expression and Prognosis Value of the KLF Family Members in Colorectal Cancer.
Huang Z, He H, Qiu F, Qian H
J Oncol. 2022; 2022:6571272.
PMID: 35345512
PMC: 8957442.
DOI: 10.1155/2022/6571272.
Human embryonic mesenchymal lung-conditioned medium promotes differentiation to myofibroblast and loss of stemness phenotype in lung adenocarcinoma cell lines.
Canals J, Navarro A, Vila C, Canals J, Diaz T, Acosta-Plasencia M
J Exp Clin Cancer Res. 2022; 41(1):37.
PMID: 35081981
PMC: 8790861.
DOI: 10.1186/s13046-021-02206-z.
The functions and prognostic value of Krüppel-like factors in breast cancer.
Zhu K, Tian Y, Li Y, Meng Q, Ge J, Cao X
Cancer Cell Int. 2022; 22(1):23.
PMID: 35033064
PMC: 8760734.
DOI: 10.1186/s12935-022-02449-6.
Transcriptional repression of E-cadherin in nickel-exposed lung epithelial cells mediated by loss of Sp1 binding at the promoter.
Zhang X, Tanwar V, Jose C, Lee H, Cuddapah S
Mol Carcinog. 2021; 61(1):99-110.
PMID: 34727382
PMC: 8665052.
DOI: 10.1002/mc.23364.
KLF7 Promotes Gastric Carcinogenesis Through Regulation of ANTXR1.
Li Y, Wang Q, Wang D, Fu W
Cancer Manag Res. 2021; 13:5547-5557.
PMID: 34285576
PMC: 8285236.
DOI: 10.2147/CMAR.S308071.
KLF11 Expression Predicts Poor Prognosis in Glioma Patients.
Xi Z, Zhang R, Zhang F, Ma S, Feng T
Int J Gen Med. 2021; 14:2923-2929.
PMID: 34234522
PMC: 8254095.
DOI: 10.2147/IJGM.S307784.
Roles of Krüppel-like factor 5 in kidney disease.
Li J, Liu L, Zhou W, Cai L, Xu Z, Rane M
J Cell Mol Med. 2021; 25(5):2342-2355.
PMID: 33523554
PMC: 7933973.
DOI: 10.1111/jcmm.16332.
Unravelling Structure, Localization, and Genetic Crosstalk of KLF3 in Human Breast Cancer.
Khan K, Safi S, Abbas A, Badshah Y, Dilshad E, Rafiq M
Biomed Res Int. 2021; 2020:1354381.
PMID: 33490232
PMC: 7803292.
DOI: 10.1155/2020/1354381.
New somatic TERT promoter variants enhance the Telomerase activity in Glioblastoma.
Pierini T, Nardelli C, Lema Fernandez A, Pierini V, Pellanera F, Nofrini V
Acta Neuropathol Commun. 2020; 8(1):145.
PMID: 32843091
PMC: 7445914.
DOI: 10.1186/s40478-020-01022-4.
Context specificity of the EMT transcriptional response.
Cook D, Vanderhyden B
Nat Commun. 2020; 11(1):2142.
PMID: 32358524
PMC: 7195456.
DOI: 10.1038/s41467-020-16066-2.
Epigenomic and Transcriptomic Changes During Human RPE EMT in a Stem Cell Model of Epiretinal Membrane Pathogenesis and Prevention by Nicotinamide.
Boles N, Fernandes M, Swigut T, Srinivasan R, Schiff L, Rada-Iglesias A
Stem Cell Reports. 2020; 14(4):631-647.
PMID: 32243845
PMC: 7160390.
DOI: 10.1016/j.stemcr.2020.03.009.
Expression of human Krüppel-like factor 3 in peripheral blood as a promising biomarker for acute leukemia.
Yan M, Liu H, Xu J, Cen X, Wang Q, Xu W
Cancer Med. 2020; 9(8):2803-2811.
PMID: 32101374
PMC: 7163096.
DOI: 10.1002/cam4.2911.
Overexpression of KLF17 Predicts a Favorable Prognosis in Patients with Oral Squamous Cell Carcinoma: A Retrospective Study.
Lee Y, Chan L, Yeh C, Lee C, Sung W
Medicina (Kaunas). 2020; 56(2).
PMID: 32019121
PMC: 7073896.
DOI: 10.3390/medicina56020057.
KLF3 is a crucial regulator of metastasis by controlling STAT3 expression in lung cancer.
Sun W, Hu S, Zu Y, Deng Y
Mol Carcinog. 2019; 58(11):1933-1945.
PMID: 31486564
PMC: 6852579.
DOI: 10.1002/mc.23072.
Stress-triggered YAP1/SOX2 activation transcriptionally reprograms head and neck squamous cell carcinoma for the acquisition of stemness.
Omori H, Sato K, Nakano T, Wakasaki T, Toh S, Taguchi K
J Cancer Res Clin Oncol. 2019; 145(10):2433-2444.
PMID: 31485767
DOI: 10.1007/s00432-019-02995-z.